Related Experiment Videos
Abstract:
Infection in ventriculo-atrial shunts implanted for relief of raised intracranial pressure may, in rare cases, result in glomerulonephritis (shunt-nephritis). Most frequently, infection with low-virulent bacteria is concerned. This results in mild or subclinical symptoms with the subsequent risk that the condition is overlooked. The glomerular damage is considered to be precipitated by deposition of immune complexes in the kidneys and subsequent activation of the complement system. The renal manifestations consist of varying degrees of proteinuria, haematuria and reduction of renal function. Treatment consists of removal of the shunt. If continued relief of pressure in the ventricular system is necessary, a ventriculo-peritoneal shunt should be implanted. Normally, the prognosis of the renal disease is good. If the diagnosis and treatment are delayed, irreversible renal damage may result. Regular control of urine (proteinuria, haematuria) and blood (Hb, serumcreatinine and serum complement) are recommended in the follow up control of patients with ventriculo-atrial shunts.
Insights
Infection of ventriculo-atrial shunts can cause rare kidney disease called shunt-nephritis. Prompt shunt removal and treatment are crucial for good prognosis and preventing irreversible renal damage.
Area of Science:
- Nephrology
- Infectious Diseases
- Neurosurgery
Background:
- Ventriculo-atrial shunts are used to manage hydrocephalus.
- Shunt infections, often with low-virulent bacteria, can lead to serious complications.
Observation:
- Infection can precipitate glomerulonephritis (shunt-nephritis) via immune complex deposition.
- Renal manifestations include proteinuria, hematuria, and reduced kidney function, often with subtle symptoms.
Findings:
- Shunt-nephritis results from immune complex-mediated glomerular damage.
- Early diagnosis and treatment (shunt removal) are vital.
Implications:
- Prompt intervention improves prognosis; delayed treatment risks irreversible renal damage.
- Regular urine and blood monitoring are recommended for patients with ventriculo-atrial shunts.